Health costs of the UK-US trade deal on pharmaceuticals
Samuel H. Cross, K Claxton, Andrew Hill
原始摘要（英文原文）· Original abstract
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade deal will harm public health and result in thousands of excess deaths